These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 2471266)

  • 1. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR
    Science; 1989 Jun; 244(4908):1072-5. PubMed ID: 2471266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum.
    Cox JH; Yewdell JW; Eisenlohr LC; Johnson PR; Bennink JR
    Science; 1990 Feb; 247(4943):715-8. PubMed ID: 2137259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation.
    Nuchtern JG; Bonifacino JS; Biddison WE; Klausner RD
    Nature; 1989 May; 339(6221):223-6. PubMed ID: 2785645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb.
    Zhou X; Glas R; Liu T; Ljunggren HG; Jondal M
    Eur J Immunol; 1993 Aug; 23(8):1802-8. PubMed ID: 8393799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.
    Lobigs M; Müllbacher A
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2676-80. PubMed ID: 8464875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective presentation of endogenous antigen by a cell line expressing class I molecules.
    Hosken NA; Bevan MJ
    Science; 1990 Apr; 248(4953):367-70. PubMed ID: 2326647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ; Rhodes J; Liew FY; Tite JP
    J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of influenza virus proteins by cytotoxic T lymphocytes.
    Townsend A; Bastin J; Bodmer H; Brownlee G; Davey J; Gotch F; Gould K; Jones I; McMichael A; Rothbard J
    Philos Trans R Soc Lond B Biol Sci; 1989 Jun; 323(1217):527-33. PubMed ID: 2474170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S.
    Hosken NA; Bevan MJ
    J Exp Med; 1992 Mar; 175(3):719-29. PubMed ID: 1311017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.
    Rötzschke O; Falk K; Deres K; Schild H; Norda M; Metzger J; Jung G; Rammensee HG
    Nature; 1990 Nov; 348(6298):252-4. PubMed ID: 1700304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitating presentation of MHC class I-restricted antigens.
    Chen W; Bennink JR; Yewdell JW
    Methods Mol Biol; 2001; 156():245-54. PubMed ID: 11068765
    [No Abstract]   [Full Text] [Related]  

  • 15. Formaldehyde inactivation of measles virus abolishes CD46-dependent presentation of nucleoprotein to murine class I-restricted CTLs but not to class II-restricted helper T cells.
    Cardoso AI; Beauverger P; Gerlier D; Wild TF; Rabourdin-Combe C
    Virology; 1995 Sep; 212(1):255-8. PubMed ID: 7676641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class I molecules retained in the endoplasmic reticulum bind antigenic peptides.
    Lapham CK; Bacík I; Yewdell JW; Kane KP; Bennink JR
    J Exp Med; 1993 Jun; 177(6):1633-41. PubMed ID: 8496682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes.
    Zhou X; Glas R; Momburg F; Hämmerling GJ; Jondal M; Ljunggren HG
    Eur J Immunol; 1993 Aug; 23(8):1796-801. PubMed ID: 8393798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.
    Jaraquemada D; Marti M; Long EO
    J Exp Med; 1990 Sep; 172(3):947-54. PubMed ID: 2388037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation.
    Hackett CJ; Yewdell JW; Bennink JR; Wysocka M
    J Immunol; 1991 May; 146(9):2944-51. PubMed ID: 1673146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced intracellular dissociation of major histocompatibility complex class I-associated peptides: a mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes.
    Sijts AJ; Pamer EG
    J Exp Med; 1997 Apr; 185(8):1403-11. PubMed ID: 9126921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.